N-terminal pro-B-type natriuretic peptide, eGFR, and progression of kidney disease in chronic kidney disease patients without heart failure
Despite its strong inverse association with eGFR, NT-proBNP was positively associated with the risk of progression of kidney disease in CKD patients with stages 1-3 without HF. Future studies should investigate the effectiveness of NT-proBNP as a predictive biomarker for the progression of kidney disease across diverse racial groups and healthcare settings.
Authors
- Junzhe Chen (ORCID: https://orcid.org/0009-0005-7573-0707)
- Sheng Nie (ORCID: https://orcid.org/0000-0002-8267-7909)
- Yi Lu (ORCID: https://orcid.org/0000-0002-7348-8903)
- Licong Su (ORCID: https://orcid.org/0000-0002-3085-909X)
- Sha Fu (ORCID: https://orcid.org/0000-0001-7465-4929)
- Yuxin Luo (ORCID: https://orcid.org/0000-0002-8078-4786)
- Andrew Fanuel Lukwaro
- Ying Tang (ORCID: https://orcid.org/0000-0002-2027-5955)
- Shiyu Zhou (ORCID: https://orcid.org/0000-0002-6564-9666)
- Shaoxin Zheng
Institutions
- Sun Yat-sen University (CN)
- Third Affiliated Hospital of Southern Medical University (CN)
- Sun Yat-sen Memorial Hospital (CN)
- Nanfang Hospital (CN)
- National Clinical Research (US)
- Southern Medical University (CN)
Publication Details
- Journal
- Clinical Kidney Journal
- Published
- 2024-09-30
- DOI
- https://doi.org/10.1093/ckj/sfae298
- Citations
- 6
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 2.41
Funders
- National Natural Science Foundation of China
- Southern Medical University
- National Key Research and Development Program of China
- Basic and Applied Basic Research Foundation of Guangdong Province